Australia is close to approving COVID-19 vaccinations for children aged between six months to five years after the Therapeutic Goods Administration (TGA) granted provisional determination to Pfizer.
This will be the first step to gaining registration on the Register of Therapeutic Goods for Pfizer, along with Moderna’s SpikeVax.
